Breadcrumb Home Business activities Â鶹Éç BioCapital Â鶹Éç BioCapital Portfolio Celladon Celladon Was in phase II/III trial with a SERCa2a gene therapy to help heart failure patients hearts to beat without increasing their oxygen consumption. Â鶹Éç BioCapital Invested 2010 IPO in 2013 – CLDN (Nasdaq) Location La Jolla, California, USA
